Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

CD4CAR T cells engage endogenous TCR to mediate antigen-independent cytotoxicity and distinct immune signatures.

Dharambir Kashyap, Malak Khalife, Lionel Apetoh, Simpla Mahato, Kelvin Lee, Huda Salman

Blood (2025) 146 (Supplement 1): 7627.

https://doi.org/10.1182/blood-2025-7627

Published: 2025

Journal Articles

MYC partners with kinase-independent PIM2 at key promoters in multiple myeloma

Christopher Schorr, Alexander Kinstedt, Daniela Petrusca, Louise Carlson, Joyce Hardwick, Julia Grace Reinke, Kelvin Lee

Blood (2025) 146 (Supplement 1): 7466.

https://doi.org/10.1182/blood-2025-7466

Published: 2025

Journal Articles

Chromothripsis drives high-risk multiple myeloma by copy number abnormalities and rewiring the epigenome to activate oncogenic programs.

Enze Liu, Nathan Becker, Sreejeta Mondal, Attaya Suvannasankha, David Coffey, Benjamin Diamond, Abhishek Pandey, Kelvin Lee, Dickran Kazandjian, Rafat Abonour, Aneta Mikulasova, Gareth Morgan, Ola Landgren, Brian Walker

Blood (2025) 146 (Supplement 1): 5693.

https://doi.org/10.1182/blood-2025-5693

Published: 2025

Journal Articles

Subclonal genomic heterogeneity shapes immune crosstalk and clinical outcomes in multiple myeloma

Parvathi Sudha, Sylvia Robertson, Sihong Li, Sean McCabe, Kelvin Lee, Rafat Abonour, Brian Walker, Attaya Suvannasankha, Travis Johnson

Blood (2025) 146 (Supplement 1): 5732.

https://doi.org/10.1182/blood-2025-5732

Published: 2025

Journal Articles

Tryptophan metabolism plays a significant role in multiple myeloma survival

Julia Grace Reinke, Kanita Chaudhry, Peng Peng, Louise Carlson, Daniela Petrusca, Christopher Schorr, Joyce Hardwick, Kelvin Lee

Blood (2025) 146 (Supplement 1): 5726.

https://doi.org/10.1182/blood-2025-5726

Published: 2025

Journal Articles

Multiomic evidence of coordinated complex rearrangements, enhancer hijacking, and epigenomic signatures in the first whole-chromosome-phased myeloma genomes

Nathan Becker, Enze Liu, Zackary Sanborn, Attaya Suvannasankha, Kelvin Lee, Dickran Kazandjian, James Hoffman, Benjamin Diamond, Abhishek Pandey, Rafat Abonour, Ola Landgren, Lisa Munding, Aneta Mikulasova, Brian Walker

Blood (2025) 146 (Supplement 1): 3928.

https://doi.org/10.1182/blood-2025-3928

Published: 2025

Journal Articles

Enhancing immunotherapy efficacy in myeloma with a novel dual-action mitochondrial toxic peptide that overcomes resistance and induces immunogenic cell death.

Smriti Gurung, Colin Crean, David Halladay, judith Anderson, John Chirgwin, Holly Lee, Nizar Bahlis, Kelvin Lee, Attaya Suvannasankha

Blood (2025) 146 (Supplement 1): 3924.

https://doi.org/10.1182/blood-2025-3924

Published: 2025

Journal Articles

Long-read direct RNA-seq reveals dynamic MM transcriptome made of novel isoforms and post-transcriptional modifications

Christopher Schorr, Nathan Becker, Pengyue Zhang, Attaya Suvannasankha, Travis Johnson, Kelvin Lee, Rafat Abonour, Brian Walker, Enze Liu

Blood (2025) 146 (Supplement 1): 3915.

https://doi.org/10.1182/blood-2025-3915

Published: 2025

Journal Articles

PIM2-dependent modulation of mitochondrial mass and function in multiple myeloma

Daniela Petrusca, Christopher Schorr, Joyce Hardwick, Louise Carlson, Peter Lander, Julia Grace Reinke, Scott Olejniczak, Kelvin Lee

Blood (2025) 146 (Supplement 1): 3254.

https://doi.org/10.1182/blood-2025-3254

Published: 2025

Journal Articles

Bridging the rural gap: Real-world teclistamab outcomes from the u.S. midwest myeloma network

Adam Stepanovic, Charles Pai, Arun Augustine, Francesca Cottini, Timothy Schmidt, Kevin Rakszawski, Malini Surapaneni, Rafat Abonour, Kelvin Lee, Attaya Suvannasankha

Blood (2025) 146 (Supplement 1): 4597.

https://doi.org/10.1182/blood-2025-4597

Published: 2025

Journal Articles

“Scotty, we need more power!”

Kelvin Lee

Blood (2025) 145 (22): 2540–2541.

https://doi.org/10.1182/blood.2025028349

Published: 2025

Journal Articles

High Body Surface Area (BSA) Is An Independent Risk Factor for Developing Bisphosphonate-Induced Osteonecrosis of the Jaw (ONJ)

Sikander Ailawadhi, Angie Elefante, Tracey L. O’Connor, Gregory E. Wilding, Wei Tan, Ellen Kossoff, Stephanie McCuthcheon, Kena C. Miller, Taimur Sher, Mehul Patel, Kelvin Lee, Asher A. Chanan-Khan

Blood (2008) 112 (11): 2786.

https://doi.org/10.1182/blood.V112.11.2786.2786

Published: 2008

Journal Articles

International Staging System (ISS) Is Superior to Durie-Salmon (DS) Staging in Predicting Overall Mortality in Multiple Myeloma (MM)

Sikander Ailawadhi, Taimur Sher, Mehul Patel, Lyudmyla Derby, Terry Mashtare, Gregory E. Wilding, Kena Miller, Alice Mohr, Kelvin Lee, Asher A. Chanan-Khan

Blood (2008) 112 (11): 2745.

https://doi.org/10.1182/blood.V112.11.2745.2745

Published: 2008

Journal Articles

Phase I Study of huN901-DM1 (BB-10901) in Patients with Relapsed and Relapsed/Refractory CD56-Positive Multiple Myeloma.

Asher A. Chanan-Khan, MD, Sundar Jagannath, MD, Nikhil C. Munshi, MD, Robert L. Schlossman, MD, Kenneth C. Anderson, MD, Kelvin Lee, MD, Dawn DePaolo, Kena C. Miller, NP, Sybil Zildjian, Robert J. Fram, MD, Qin

Blood (2007) 110 (11): 1174.

https://doi.org/10.1182/blood.V110.11.1174.1174

Published: 2007

Journal Articles

Bortezomib in Combination with Pegylated Liposomal Doxorubicin and Thalidomide (VDT) for the Treatment of Previously Untreated Multiple Myeloma.

Asher A. Chanan-Khan, MD, Kena C. Miller, NP, Dawn DePaolo, Swaminathan Padmanabhan, MD, Amy Whitworth, Sikander Ailawadhi, MD, Kelvin Lee, MD, Myron S. Czuczman, MD

Blood (2007) 110 (11): 3614.

https://doi.org/10.1182/blood.V110.11.3614.3614

Published: 2007

Journal Articles

Association of Complement with Microvascular Endothelial Cell Injury in Thrombotic Microangiopathy In Vivo and in In Vitro Model Systems.

Brian A. Di Carlo, MD, Radu Stefanescu, MD, Kelvin Lee, PhD, Wei Yin, PhD, Rozbeh Modaressi, PhD, Ellinor I.B. Peerschke, MD, Jeffrey Laurence, MD

Blood (2006) 108 (11): 1465.

https://doi.org/10.1182/blood.V108.11.1465.1465

Published: 2006

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

CD4CAR T cells engage endogenous TCR to mediate antigen-independent cytotoxicity and distinct immune signatures.

MYC partners with kinase-independent PIM2 at key promoters in multiple myeloma

Chromothripsis drives high-risk multiple myeloma by copy number abnormalities and rewiring the epigenome to activate oncogenic programs.

Subclonal genomic heterogeneity shapes immune crosstalk and clinical outcomes in multiple myeloma

Tryptophan metabolism plays a significant role in multiple myeloma survival

Multiomic evidence of coordinated complex rearrangements, enhancer hijacking, and epigenomic signatures in the first whole-chromosome-phased myeloma genomes

Enhancing immunotherapy efficacy in myeloma with a novel dual-action mitochondrial toxic peptide that overcomes resistance and induces immunogenic cell death.

Long-read direct RNA-seq reveals dynamic MM transcriptome made of novel isoforms and post-transcriptional modifications

PIM2-dependent modulation of mitochondrial mass and function in multiple myeloma

Bridging the rural gap: Real-world teclistamab outcomes from the u.S. midwest myeloma network

“Scotty, we need more power!”

High Body Surface Area (BSA) Is An Independent Risk Factor for Developing Bisphosphonate-Induced Osteonecrosis of the Jaw (ONJ)

International Staging System (ISS) Is Superior to Durie-Salmon (DS) Staging in Predicting Overall Mortality in Multiple Myeloma (MM)

Phase I Study of huN901-DM1 (BB-10901) in Patients with Relapsed and Relapsed/Refractory CD56-Positive Multiple Myeloma.

Bortezomib in Combination with Pegylated Liposomal Doxorubicin and Thalidomide (VDT) for the Treatment of Previously Untreated Multiple Myeloma.

Association of Complement with Microvascular Endothelial Cell Injury in Thrombotic Microangiopathy In Vivo and in In Vitro Model Systems.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only